bioMérieux makes strategic investment in Oxford Nanopore
Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore”), the company delivering a new generation of nanopore-based molecular sensing…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Oct 23
Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore”), the company delivering a new generation of nanopore-based molecular sensing…
12 Oct 23
KERN & SOHN GmbH is presenting the new products in its medical technology range at MEDICA in Düsseldorf…
11 Oct 23
Today, UPS Healthcare has launched UPS® Pickup Point locations for laboratory customers across key European healthcare markets including…
29 Sep 23
Interview with Anni Matthes and Dr. Robby Markwart, Research associates, Institute of General Practice and Family Medicine at…
29 Sep 23
During HUAWEI CONNECT 2023, Huawei held the first intelligent healthcare summit themed "Build a Digital Health Community to…
20 Sep 23
Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, today announced it will provide Cepheid's Xpert® MTB/RIF Ultra…
20 Sep 23
Deep Bio, a leader in artificial intelligence (AI)-powered cancer diagnostics, announced today that it has obtained marketing authorization…
19 Sep 23
High calibre speakers at the MEDICA MEDICINE + SPORTS CONFERENCE illuminate new methods and their practical uses
06 Sep 23
Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, unveiled its…
05 Sep 23
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products,…